title: Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Celant
authors.forename: Guido
authors.initials: G
authors.lastname: Chichino
authors.forename: Barbara
authors.initials: B
authors.lastname: Dal Bello
authors.forename: Marco
authors.initials: M
authors.lastname: Massarotti
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Minoli
authors.forename: Bianca
authors.initials: B
authors.lastname: Marasini
mesh_terms: D000208:Acute Disease; D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006505:Hepatitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B